Medtronic PLC (MDT)
Return on equity (ROE)
| Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Apr 26, 2024 | Jan 31, 2024 | Jan 26, 2024 | Oct 31, 2023 | Oct 27, 2023 | Jul 31, 2023 | Jul 28, 2023 | Apr 30, 2023 | Apr 28, 2023 | Jan 31, 2023 | Jan 27, 2023 | Oct 31, 2022 | Oct 28, 2022 | Jul 31, 2022 | Jul 29, 2022 | Apr 30, 2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 4,260,000 | 3,620,000 | 3,672,000 | 3,952,000 | 4,207,000 | 4,462,000 | 3,931,000 | 3,400,000 | 3,670,000 | 3,940,000 | 4,371,000 | 4,802,000 | 4,050,000 | 3,298,000 | 3,005,000 | 2,712,000 | 3,770,000 | 4,828,000 | 5,379,000 | 5,930,000 |
| Total stockholders’ equity | US$ in thousands | 49,387,000 | 48,494,000 | 47,947,000 | 50,214,000 | 50,214,000 | 51,792,000 | 51,792,000 | 51,460,000 | 51,460,000 | 51,178,000 | 51,178,000 | 51,483,000 | 51,483,000 | 51,441,000 | 51,441,000 | 51,880,000 | 51,880,000 | 52,672,000 | 52,672,000 | 52,551,000 |
| ROE | 8.63% | 7.46% | 7.66% | 7.87% | 8.38% | 8.62% | 7.59% | 6.61% | 7.13% | 7.70% | 8.54% | 9.33% | 7.87% | 6.41% | 5.84% | 5.23% | 7.27% | 9.17% | 10.21% | 11.28% |
January 31, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $4,260,000K ÷ $49,387,000K
= 8.63%
The return on equity (ROE) for Medtronic PLC has shown fluctuations over the analyzed period. Starting at 11.28% in April 2022, the ROE decreased to 5.23% by October 2022, indicating a decline in the company's profitability in generating returns for its shareholders. However, there was a slight improvement in the ROE to 9.33% by April 2023, followed by fluctuations around the 7-8% range until January 2025 when it reached 8.63%.
Overall, while there have been ups and downs in Medtronic PLC's ROE, the company has managed to maintain a relatively stable performance in generating returns for its equity holders. It is important for the company to continue monitoring and improving its ROE to ensure sustainable long-term profitability and shareholder value.
Peer comparison
Jan 31, 2025